Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-01-31 8:41 pm Purchase | 13G | CHIMERIX INC CMRX | Opaleye Management Inc. | 5,580,000 6.4% | 1,623,500 (+41.03%) | View |
| 2022-01-31 8:38 pm Sale | 13G | OCULAR THERAPEUTIX INC OCUL | Opaleye Management Inc. | 5,974,800 7.8% | -535,200 (-8.22%) | View |
| 2022-01-26 11:06 am Unchanged | 13G | SANUWAVE HEALTH INC SNWV | Opaleye Management Inc. | 31,428,571 6.5% | 0 (Unchanged) | View |
| 2022-01-26 11:00 am Sale | 13G | ADAMAS PHARMACEUTICALS INC ADMS | Opaleye Management Inc. | 0 0% | -1,487,800 (Position Closed) | View |
| 2022-01-25 9:43 pm Purchase | 13G | HARROW INC HROW | Opaleye Management Inc. | 3,285,000 12.2% | 219,584 (+7.16%) | View |
| 2022-01-24 4:05 pm Sale | 13G | ETON PHARMACEUTICALS INC ETON | Opaleye Management Inc. | 2,385,000 9.69% | -1,307,700 (-35.41%) | View |
| 2021-06-17 4:40 pm Purchase | 13G | ETON PHARMACEUTICALS INC ETON | Opaleye Management Inc. | 3,692,700 15.07% | 1,067,700 (+40.67%) | View |
| 2021-02-12 5:20 pm Sale | 13G | STEREOTAXIS INC STXS | Opaleye Management Inc. | 3,021,436 4.1% | -1,091,064 (-26.53%) | View |
| 2021-02-12 5:20 pm Sale | 13G | EDAP TMS S.A. SPONS ADR EDAP | Opaleye Management Inc. | 657,500 2.26% | -1,127,500 (-63.17%) | View |
| 2021-02-12 5:20 pm Purchase | 13G | SANUWAVE HEALTH INC SNWV | Opaleye Management Inc. | 31,428,571 6.73% | 16,710,857 (+113.54%) | View |
| 2021-02-12 5:20 pm Purchase | 13G | CHIMERIX INC CMRX | Opaleye Management Inc. | 3,956,500 6.32% | 813,600 (+25.89%) | View |
| 2021-02-12 5:20 pm Purchase | 13G | INFINITY PHARMACEUTICALS INC C INFI | Opaleye Management Inc. | 3,171,800 4.94% | 171,400 (+5.71%) | View |
| 2021-02-12 5:20 pm Purchase | 13G | ADAMAS PHARMACEUTICALS INC ADMS | Opaleye Management Inc. | 1,487,800 5.22% | 61,800 (+4.33%) | View |
| 2021-02-12 5:20 pm Purchase | 13G | HARROW INC HROW | Opaleye Management Inc. | 3,065,416 11.91% | 3,065,416 (New Position) | View |
| 2021-02-12 5:20 pm Purchase | 13G | CARDIFF ONCOLOGY INC CRDF | Opaleye Management Inc. | 1,662,500 4.71% | 414,500 (+33.21%) | View |
| 2021-02-12 5:20 pm Sale | 13G | AVENUE THERAPEUTICS INC NE ATXI | Opaleye Management Inc. | 0 0% | -1,035,000 (Position Closed) | View |
| 2021-02-12 5:20 pm Purchase | 13G | FORTRESS BIOTECH INC FBIO | Opaleye Management Inc. | 3,887,500 4.15% | 62,400 (+1.63%) | View |
| 2021-02-12 5:20 pm Purchase | 13G | TRACON PHARMACEUTICALS INC TCON | Opaleye Management Inc. | 2,518,371 17.04% | 2,518,371 (New Position) | View |
| 2021-02-12 5:20 pm Purchase | 13G | FS DEV CORP COM FSDC | Opaleye Management Inc. | 704,400 5.63% | 36,000 (+5.39%) | View |
| 2021-02-12 5:20 pm Sale | 13G | SEMLER SCIENTIFIC INC SMLR | Opaleye Management Inc. | 290,500 4.36% | -43,000 (-12.89%) | View |